CD163L1 and neoplasm: Cluster M0 highly expressed immunosuppressive and angiogenic phenotype-related markers (SLC40A1, NRP1, and CD36) (45–47) and promote tumor progression associated with markers (CD163 and CD163L1) (48, 49).